Trial of Spirometry Fundamentals™ in the Primary Care Setting
Randomized Controlled Trial of Spirometry Fundamentals™ in the Primary Care Setting
Spirometry is a recommended component of asthma diagnosis and treatment in the primary care setting, yet few primary care providers report routine use of spirometry in the provision of care for their asthma patients. Misclassification of asthma severity has been reported when assessment is based on symptoms alone. This misclassification can lead to inadequate treatment that may result in increased morbidity and increased healthcare utilization/cost. However, even when spirometry is utilized to aid in asthma severity classification, primary care providers have a high rate of failing to meet the quality goals for testing established by the American Thoracic Society.
The goal of this study is to evaluate the effectiveness of the Spirometry Fundamentals™ tool in training primary care providers and their staff in producing high-quality flow-volume curves as compared to existing training modalities and to gather information in a 'real-world' setting that can be used to improve Spirometry Fundamentals™.
Обзор исследования
Статус
Условия
Вмешательство/лечение
Подробное описание
Currently few self-paced, distance learning programs exist that train staff to perform good quality spirometry tests. This study evaluates the effectiveness of a distance-learning tool for training primary care providers and their medical assistants in the use of spirometry to assist in managing obstructive lung disease (asthma and COPD). This tool is called "Spirometry Fundamentals™: A basic guide to lung function testing". It is a computer-based training program that teaches primary care providers and their staff what spirometry is, how it can be used, the techniques required to perform high-quality spirometry, and clinical interpretation of the spirometric data.
We evaluated the effectiveness of Spirometry Fundamentals in the primary care setting by conducting a randomized controlled trial (RCT). Study participants were primary care physicians (MDs or DOs) and their staff (medical assistants (MAs) or nurses (RNs)) and were recruited as study pairs. The role of the MDs was to utilize spirometry in clinical care by ordering spirometry tests based on their clinical judgment, and the role of the MAs was to perform the spirometry. The patients performed the spirometry as part of their usual care were not considered study subjects.
Тип исследования
Регистрация (Действительный)
Фаза
- Непригодный
Контакты и местонахождение
Места учебы
-
-
Washington
-
Seattle, Washington, Соединенные Штаты, 98195
- University of Washington
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Описание
Inclusion Criteria:
- Subjects must have internet access in order to transmit spirometry curve and survey data.
- Subjects must have access to a computer with Windows 2000 /Mac OS 10 or higher in order to view Spirometry Fundamentals™.
- Subjects must have access to a ndd Easyone spirometer.
Exclusion Criteria:
- Subjects who lack internet access which will be needed to transmit study data
- Subjects who lack access to a computer with Windows 2000 /Mac OS 10 or higher which will be needed to view Spirometry Fundamentals™.
- Subjects who lack access to a ndd Easyone spirometer.
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Исследования в области здравоохранения
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Нет (открытая этикетка)
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Без вмешательства: Стандарт заботы
|
|
|
Экспериментальный: Intervention
Spirometry Fundamentals™ CD training program
|
MD-MA pairs randomized to the intervention arm of the study received 2 copies of the Spirometry Fundamentals™ CD.
Included with the CDs was a letter explaining that each member of the MD-MA pair should view the CD at their convenience within the following 3 weeks.
This letter included instructions on how to access the study website in order to complete an evaluation survey after viewing the CD.
|
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Spirometry test quality
Временное ограничение: Four months for controls; six months for intervention sites
|
Percentage of acceptable quality spirometry tests as determined by standards set by the American Thoracic Society.
|
Four months for controls; six months for intervention sites
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Effect of frequency of spirometry use on primary outcome
Временное ограничение: Four months for controls; six months for intervention sites
|
Examined whether frequency of spirometry use related to the percent of passing testing sessions conducted by the office.
|
Four months for controls; six months for intervention sites
|
|
Effect of practice location on primary outcome
Временное ограничение: Four months for controls; six months for intervention sites
|
Examined whether practice location (private/community, hospital/university) related to the percent of passing testing sessions conducted by the office.
|
Four months for controls; six months for intervention sites
|
|
Effect of practice type on primary outcome
Временное ограничение: Four months for controls; six months for intervention sites
|
Examined whether practice type (pediatric/non-pediatric) related to the percent of passing testing sessions conducted by the office.
|
Four months for controls; six months for intervention sites
|
|
Effect of practice structure on primary outcome
Временное ограничение: Four months for controls; six months for intervention sites
|
Examined whether practice structure related to the percent of passing testing sessions conducted by the office.
|
Four months for controls; six months for intervention sites
|
|
Effect of months of spirometry use on primary outcome
Временное ограничение: Four months for controls; six months for intervention sites
|
Examined whether months of spirometry use by practice (prior to participating in study) related to the percent of passing testing sessions conducted by the office.
|
Four months for controls; six months for intervention sites
|
Соавторы и исследователи
Спонсор
Следователи
- Главный следователь: Rita Mangione-Smith, MD, MPH, University of Washington/Seattle Children's Hospital
- Главный следователь: James W Stout, MD, MPH, University of Washington
Публикации и полезные ссылки
Полезные ссылки
Даты записи исследования
Изучение основных дат
Начало исследования
Первичное завершение (Действительный)
Завершение исследования (Действительный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Оценивать)
Обновления учебных записей
Последнее опубликованное обновление (Оценивать)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
- 31552-E/A
- A26829 (Другой номер гранта/финансирования: American Thoracic Society)
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .
Клинические исследования Spirometry Fundamentals™ Training CD
-
University of CologneMedtronicНеизвестный
-
Medtronic Spinal and BiologicsЗавершенныйДегенеративное заболевание дисков
-
Intec Pharma Ltd.НеизвестныйБолезнь ПаркинсонаСоединенные Штаты, Испания, Италия, Израиль, Польша, Соединенное Королевство, Болгария, Германия, Словакия, Украина
-
Intec Pharma Ltd.НеизвестныйБолезнь ПаркинсонаСоединенные Штаты, Израиль, Италия, Испания, Соединенное Королевство, Болгария, Германия, Польша, Словакия, Украина
-
Mutual Pharmaceutical Company, Inc.ЗавершенныйЗдоровый; взрослый; волонтер; колхицин; Фармакокинетика; Дилтиазем; Цитохром р450 3А4; Р-гликопротеинСоединенные Штаты